Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.80% | $321.16M | €458.08B | 67.61% | 76 Outperform | |
| Novartis AG | 1.78% | $204.29M | CHF244.33B | 31.88% | 80 Outperform | |
| HSBC Holdings | 1.28% | $147.24M | £218.16B | 44.94% | 80 Outperform | |
| AstraZeneca | 1.24% | $142.74M | $324.77B | 32.79% | 80 Outperform | |
| Nestlé SA | 1.12% | $129.20M | CHF199.86B | 12.45% | 71 Outperform | |
| Siemens | 1.10% | $125.97M | €183.95B | 8.14% | 74 Outperform | |
| SAP SE | 1.08% | $124.35M | €193.15B | -37.43% | 66 Neutral | |
| ABB Ltd | 1.06% | $121.90M | kr1.49T | 35.01% | 78 Outperform | |
| Roche Holding AG | 1.01% | $116.11M | CHF294.92B | 46.36% | 73 Outperform | |
| Commonwealth Bank of Australia | 0.96% | $110.78M | AU$297.63B | 11.29% | 64 Neutral |